Factors contributing to the high CAGR are ease of consultation, increasing implementation of digital pathology and rising prevalence of cancer. Further, technological advancements, product launches, collaborations, partnerships and acquisitions are anticipated to fuel the overall market growth of global digital pathology market across the globe
Market Size – USD 540.9 Million in 2020, Market Growth – CAGR of 12.2%, Market Trends – Product Launches and Research for Advanced Tech Developments
Based on current analysis the global digital pathology market was valued at USD 540.9 Million in 2020 and is expected to reach USD 1,432.4 Million by 2028, at a CAGR of 12.2%. Digital pathology is an innovation predominantly committed to improve operational efficiency, minimization of laboratory expenses, enhanced productivity, improving treatment decisions and patient care. Interpretation of pathology information generated from a digitized glass slide is known as digital pathology. Virtual microscopy is a part of digital pathology which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. Digital pathology is presently considered as one of the most promising areas of diagnostic medicine in order to achieve accurate, feasible and faster diagnosis, prognosis and prediction of cancer and other important diseases. Market drivers for digital pathology market are growing applications of digital pathology, ease of consultation, increasing implementation of digital pathology to boost lab efficiency, rising prevalence of cancer, and increasing interventions by governments and initiatives by key industry players.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1493
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Market Segmentation by Types:
Product (Revenue in USD Million; 2020–2028)
• scanners
• software
• communication systems
• slide management systems
• storage systems
Type (Revenue in USD Million; 2020–2028)
• Human pathology
• Veterinary pathology
Market Segmentation by Applications:
Applications (Revenue in USD Million; 2020–2028)
• Teleconsultation
• Disease Diagnosis
• Drug Discovery and development
• Cancer cell detection
• Others
End Use (Revenue in USD Million; 2020–2028)
• Pathology labs
• Pharmaceutical & Biotechnology Companies
• Hospitals
• Academic & Research Institutes
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1493
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Digital Pathology market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/digital-pathology-market
Key findings from the report
• There were an estimated 15.5 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 20.3 million by 2028. Due to increase in the chances of survival, it is expected to increase the market revenue of digital pathology
• Biotech and pharma companies are predicted to showcase a stable growth during the forecast period. The growth is credited to enlarged use of digital pathology in drug development, oncology clinical trials, and preclinical GLP pathology. Cumulative occurrence of cancer and demand for better treatment options is further fueling the market
• Teleconsultation segment in applications of digital pathology market is estimated to account for the highest share of 45.8% in the market due to accessibility to patients in remote areas with specialist pathological consultation
• Asia-Pacific regional segment of the digital pathology market is expected to register itself as highest growing segment during the forecasted period, at a CAGR of 13.4%; owing it to the qualitative as well as quantitative market potential offered in developing nations such as China & India
• Owing to increasing adoption of digital pathology solution worldwide, the scanners segment is expected to dominate the digital pathology market with growing CAGR of 11.7%
• In 2020, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and it is anticipated that approximately 609,640 people will die from the disease. Thus, it is likely to prosper the digital pathology market due to high prevalence of the target disease
• Roughly 38.4% of men and women are likely to be diagnosed with cancer at some point during their lifetimes. In 2017, it was estimated that around 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1493
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the